{"id":484299,"date":"2021-04-29T08:07:31","date_gmt":"2021-04-29T12:07:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/"},"modified":"2021-04-29T08:07:31","modified_gmt":"2021-04-29T12:07:31","slug":"converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/","title":{"rendered":"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n TORONTO<\/span> and GATINEAU<\/span>, QC, April 29, 2021<\/span> \/PRNewswire\/ – Converge Technology Solutions Corp. (“Converge<\/b>” or “the Company<\/b>“) (TSX: CTS)\u00a0(FSE: 0ZB) (OTCQX: CTSDF) a software-enabled IT & Cloud Solutions provider, in partnership with Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over-the-counter sale of the LUCIRA\u2122 CHECK IT test kit that delivers PCR quality molecular accuracy in 30 minutes or less at home. <\/p>\n

\n

\n
\n \"Converge
\n <\/a>\n <\/p>\n<\/p><\/div>\n

This product is the first and only FDA EUA authorized, single-use, over the counter molecular diagnostic test for COVID-19 that can be self-administered by individuals at home. The Lucira test is also FDA EUA authorized for use in a physician’s office. It is authorized and available for individuals with or without symptoms and can be ordered from lucirahealth.com for $55<\/span>. Converge partnered with Lucira to support people who would like to quickly receive confirmation of their test results for work and other needs by developing a secure, text-based way for people with smartphones to receive a free LUCI PASS\u2122 and verified test to their phone.\u00a0\u00a0\u00a0\u00a0<\/p>\n

“Converge is honored to have been part of the development of the first FDA EUA authorized, self-administered COVID-19 home test,” stated Shaun Maine<\/span>, CEO of Converge. “The opportunity to use Converge’s solution capabilities in partnership with Lucira’s health testing platform is an exciting use of technology to help others monitor their health in a positive and empowering way. The ability to order and test for COVID-19 at home is a huge step forward in increased access to health options that fit every lifestyle. Additionally, the verification of a negative COVID test via the LUCI PASS\u2122 brings us one step closer to in-person interactions, creating shared trust to safely travel, work, or attend events with others.”<\/p>\n

“Seeing the LUCI PASS\u2122 in action at a recent Philadelphia<\/span> 76ers game was really exciting. It shows how something as simple as a digital Lucira test result verification can play a role in helping the economy reopen. Users simply take the Lucira at home test and use the LUCI portal to obtain their LUCI PASS\u2122 with their verified negative COVID test result,” said Dr. Jonathan Gough<\/span>, Project Lead for Lucira. “We designed LUCI to be intuitive and easy to use. It doesn’t even require an app. It’s something anyone with a smartphone can use and it opens up a world of possibility for users to easily show their negative COVID status to attend events like NBA games, work, and travel.”<\/p>\n

\n About Converge
<\/b>Converge Technology Solutions Corp. is a software-enabled IT & Cloud Solutions provider\u00a0focused on delivering industry-leading solutions and services. Converge’s regional sales and services organizations deliver advanced analytics, cloud, and cybersecurity offerings to clients across various industries. The Company supports these solutions with managed services, digital infrastructure, and talent expertise offerings across all major IT vendors in the marketplace. This multi-faceted approach enables Converge to address the unique business and technology requirements for all clients in the public and private sectors. For more information, visit convergetp.com<\/a>.<\/p>\n

\n About Lucira Health, Inc.
<\/b>Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA\u2122 CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kit (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test-301280169.html<\/a><\/p>\n

SOURCE Converge Technology Solutions Corp.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire TORONTO and GATINEAU, QC, April 29, 2021 \/PRNewswire\/ – Converge Technology Solutions Corp. (“Converge” or “the Company“) (TSX: CTS)\u00a0(FSE: 0ZB) (OTCQX: CTSDF) a software-enabled IT & Cloud Solutions provider, in partnership with Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over-the-counter sale of the LUCIRA\u2122 CHECK IT test kit that delivers PCR quality molecular accuracy in 30 minutes or less at home. This product is the first and only FDA EUA authorized, single-use, over the counter molecular diagnostic test for COVID-19 that can be self-administered by individuals at home. The … <\/p>\n

Continue reading “Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484299","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nConverge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TORONTO and GATINEAU, QC, April 29, 2021 \/PRNewswire\/ – Converge Technology Solutions Corp. (“Converge” or “the Company“) (TSX: CTS)\u00a0(FSE: 0ZB) (OTCQX: CTSDF) a software-enabled IT & Cloud Solutions provider, in partnership with Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over-the-counter sale of the LUCIRA\u2122 CHECK IT test kit that delivers PCR quality molecular accuracy in 30 minutes or less at home. This product is the first and only FDA EUA authorized, single-use, over the counter molecular diagnostic test for COVID-19 that can be self-administered by individuals at home. The … Continue reading "Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T12:07:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1499003\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test\",\"datePublished\":\"2021-04-29T12:07:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/\"},\"wordCount\":646,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1499003\\\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/\",\"name\":\"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1499003\\\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg\",\"datePublished\":\"2021-04-29T12:07:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1499003\\\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1499003\\\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/","og_locale":"en_US","og_type":"article","og_title":"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test - Market Newsdesk","og_description":"PR Newswire TORONTO and GATINEAU, QC, April 29, 2021 \/PRNewswire\/ – Converge Technology Solutions Corp. (“Converge” or “the Company“) (TSX: CTS)\u00a0(FSE: 0ZB) (OTCQX: CTSDF) a software-enabled IT & Cloud Solutions provider, in partnership with Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over-the-counter sale of the LUCIRA\u2122 CHECK IT test kit that delivers PCR quality molecular accuracy in 30 minutes or less at home. This product is the first and only FDA EUA authorized, single-use, over the counter molecular diagnostic test for COVID-19 that can be self-administered by individuals at home. The … Continue reading \"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T12:07:31+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1499003\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test","datePublished":"2021-04-29T12:07:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/"},"wordCount":646,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1499003\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/","name":"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1499003\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg","datePublished":"2021-04-29T12:07:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1499003\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1499003\/Converge_Technology_Solutions_Corp__Converge_Partners_with_Lucir.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home Test"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484299"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484299\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}